Athens Medical C.S.A. Cash Flow-to-Debt Ratio

Latest as of June 2023: 0.01x

Athens Medical C.S.A. cash flow-to-debt ratio. Athens Medical C.S.A. (IATR) has a Cash Flow-to-Debt Ratio of 0.01x as of June 2023, meaning its operating cash flow of €3.17 Million could theoretically repay 0% of its total liabilities (€347.82 Million) in one year. Check Athens Medical C.S.A. (IATR) cash earnings ratio to evaluate the quality of earnings relative to operating cash generation.

CF-to-Debt Ratio

0.01x
Operating CF / Total Liabilities

Operating Cash Flow

€3.17 Million
EUR

Total Liabilities

€347.82 Million
EUR

Data as of

Jun 2023
Most recent filing

Cash Flow-to-Debt Ratio of Athens Medical C.S.A. (2014–2024)

Cash flow-to-debt ratio of Athens Medical C.S.A. from 2014 to 2024. Historical debt coverage capacity for Athens Medical C.S.A. across 11 annual periods. Check cash flow reinvestment rate of Athens Medical C.S.A. to assess the company's total reinvestment commitment from operating cash flow.

Athens Medical C.S.A. Cash Flow-to-Debt Ratio by Year (2014–2024)

Athens Medical C.S.A. cash flow-to-debt ratio by year from 2014 to 2024. Year-by-year debt coverage analysis for Athens Medical C.S.A.. For the full cash flow conversion analysis, see Athens Medical C.S.A. cash conversion from operations.

Year CF-to-Debt Ratio Operating CF (EUR) Total Liabilities YoY Change
2024 0.12x €46.44 Million €387.05 Million ▲ +69.3%
2023 0.07x €26.13 Million €368.57 Million ▲ +17900.6%
2022 0.00x €124.00K €314.84 Million ▼ -99.2%
2021 0.05x €15.75 Million €320.69 Million ▼ -59.5%
2020 0.12x €40.21 Million €331.48 Million ▲ +11.3%
2019 0.11x €31.50 Million €289.03 Million ▲ +56.7%
2018 0.07x €20.02 Million €287.84 Million ▲ +1460.5%
2017 -0.01x €-1.52 Million €298.28 Million ▼ -116.1%
2016 0.03x €9.78 Million €308.01 Million ▼ -23.3%
2015 0.04x €12.89 Million €311.40 Million ▲ +254.4%
2014 0.01x €3.58 Million €306.93 Million —
Cash Flow-to-Debt Ratio = Operating Cash Flow / Total Liabilities. Higher is better for debt service capacity.